Faculty, Staff and Student Publications
Publication Date
1-1-2023
Journal
International Journal of Clinical and Health Psychology
Abstract
BACKGROUND: Major depressive disorder (MDD) is a serious mood disorder and leading cause of disability. Despite treatment advances, approximately 30% of individuals with MDD do not achieve adequate clinical response. Better understanding the biological mechanism(s) underlying clinical response to specific psychopharmacological interventions may help fine tune treatments in order to further modulate their underlying mechanisms of action. However, little is known regarding the effect of non-pharmacological treatments (NPTs) on candidate molecular biomarker levels in MDD. This review aims to identify molecular biomarkers that may elucidate NPT response for MDD.
METHODS: We performed a systematic review and a multilevel linear mixed-effects meta-analyses, and a meta-regression. Searches were performed in PubMed, Scopus, and PsycINFO in October 2020 and July 2021.
RESULTS: From 1387 retrieved articles, 17 and six studies were included in the systematic review and meta-analyses, respectively. Although there was little consensus associating molecular biomarker levels with symptomology and/or treatment response, brain metabolites accessed via molecular biomarker-focused neuroimaging techniques may provide promising information on whether an individual with MDD would respond positively to NPTs. Furthermore, non-invasive brain stimulation interventions significantly increased the expression of neurotrophic factors (NTFs) compared to sham/placebo, regardless of add-on pharmacological treatment.
CONCLUSIONS: NTFs are candidate biomarkers to fine-tune NIBS for MDD treatment.
Keywords
Major depressive disorder, Biomarkers, Non-pharmacological treatment, Cognitive behavioral therapy, Non-invasive brain stimulation
Included in
Medical Molecular Biology Commons, Medical Specialties Commons, Mental and Social Health Commons, Psychiatry and Psychology Commons, Psychology Commons
Comments
Supplementary Materials
PMID: 36762034